Dobran M, Iacoangeli M, Scortichini A R, Mancini F, Benigni R, Nasi D, Gladi M, Scerrati M
G Chir. 2017 Mar-Apr;38(2):66-70. doi: 10.11138/gchir/2017.38.2.066.
Chronic subdural hematoma (CSDH) is typically in elderly and rarely in young people. To prevent complications and re-bleeding after surgical treatment of CSDH it is important to assess the risk factors as coagulation disorders especially in young patients (below 65 years) with no history of head trauma, alcohol abuse or anticoagulant therapy.
This study consists of 16 patients (12 males, 4 females) with age ranging from 27 to 59 years (median 48,25 years) operated for CSDH. All patients are submitted to routine coagulation parameters pre-operatively and complete screening for unknown coagulation deficit in the follow-up.
Factor VII was altered in 6 out of 16 patients and one patient had the alteration of the Von Willebrand factor. Recurrence occurred in 4 out of 16 patients and all of these patients were positive for factor VII deficiency. Three pts were in therapy with ASA. No patients were alcoholists or suffered from hematological disease.
In this study we documented that the decreased activity of VII factor may play a role in the pathophysiology and recurrence of spontaneous CSDH in young adults. We suggest that for young patients aged under 65 y.o. suffered from CSDH the screening of coagulation factors is useful to planning a safely and correct surgical therapy.
慢性硬膜下血肿(CSDH)多见于老年人,在年轻人中较为罕见。为预防CSDH手术治疗后的并发症和再出血,评估危险因素如凝血障碍非常重要,尤其是对于无头部外伤、酗酒或抗凝治疗史的年轻患者(65岁以下)。
本研究包括16例接受CSDH手术的患者(12例男性,4例女性),年龄在27至59岁之间(中位数48.25岁)。所有患者术前均接受常规凝血参数检查,并在随访中进行未知凝血缺陷的全面筛查。
16例患者中有6例因子VII异常,1例患者血管性血友病因子异常。16例患者中有4例复发,所有这些患者因子VII缺乏均为阳性。3例患者正在接受阿司匹林治疗。无患者酗酒或患有血液系统疾病。
在本研究中,我们记录到因子VII活性降低可能在年轻成年人自发性CSDH的病理生理和复发中起作用。我们建议,对于65岁以下患有CSDH的年轻患者,凝血因子筛查有助于规划安全、正确的手术治疗。